This landmark paper examines the theory underlying the reporting of myopia control efficacy and the sequelae of such investigation. The authors propose an alternate method of reporting efficacy; Cumulative Absolute Reduction in Axial Elongation (CARE), which conveys the benefit that a child receiving a specified treatment might expect, independent of age, progression rate, refractive error and ethnicity over a stated time period.
The much anticipated BLINK study has just been published! Hot off the press, we examine the results comparing +1.50 and +2.50 centre distance MFCLs, explain the study and describe how these results compare to other myopia controlling contact lenses.
Can centile growth charts for axial length growth be used to predict success with a myopia control intervention? The three-year MiSight data was modelled against population data as a step towards validated normative data.
AAO2019 Meeting and third biannual World Congress of Optometry– Addressing the global myopia burden: guest summary by Sally Dillehay.
The latest from the Global Specialty Lens Symposium 2020 (GSLS2020) on research, intervention updates and young adult myopia progression.
Announcing Part 3 of 4 of exciting updates from the 2019 biannual International Myopia Conference! You’ll find links to parts 1, 2 and 4 at the end, however read on for updates on OrthoK, MYLO and MiSight!
Welcome to Part 2 of 4 fabulous updates from the 2019 biannual International Myopia Conference! Read on for more about predicting axial length growth, refractive growth and translating statistics into real world progression. Mark and Noel’s latest research on understanding myopia control efficacy is described below.
Part 1 on the Annual Association for Research in Vision & Ophthalmology (ARVO) . The latest findings in Myopia control, management & treatment.
